Filing Details
- Accession Number:
- 0001181431-13-019217
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-27 20:05:20
- Reporting Period:
- 2013-03-25
- Filing Date:
- 2013-03-27
- Accepted Time:
- 2013-03-27 20:05:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1373707 | Tetraphase Pharmaceuticals Inc | TTPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1571997 | Ph.d. R. Steven Gullans | 800 Boylston St. Suite 2825 Boston MA 02199 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-03-25 | 972,384 | $0.00 | 972,384 | No | 4 | C | Indirect | By Excel Medical Fund, L.P. |
| Common Stock | Acquisiton | 2013-03-25 | 496,121 | $7.00 | 1,468,505 | No | 4 | P | Indirect | By Excel Medical Fund, L.P. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | By Excel Medical Fund, L.P. |
| No | 4 | P | Indirect | By Excel Medical Fund, L.P. |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series C Convertible Participating Preferred Stock | Disposition | 2013-03-25 | 28,199,144 | $0.00 | 972,384 | $0.00 |
| Common Stock | Non-qualified stock option (right to buy) | Acquisiton | 2013-03-25 | 20,000 | $0.00 | 20,000 | $7.07 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 20,000 | 2023-03-24 | No | 4 | A | Direct |
Footnotes
- The Series A-1. Series A-2, Series B and Series C Convertible Preferred Stock converted into Common Stock on a 1-for-29 basis upon the closing of the Issuer's initial public offering without payment of consideration.
- Held by Excel Medical Fund, L.P. Excel Medical Ventures, LLC is the general partner of Excel Medical Fund, L.P. Steven R. Gullans is a Managing Director of Excel Medical Ventures, LLC. Mr. Gullans may be deemed to share voting and dispositive power with respect to all shares held by Excel Medical Fund, L.P. Mr. Gullans disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
- Not applicable.
- Vests in equal quarterly installments over a three-year period measured from the date of grant.
Billionaire Hedge Funds
